Q and A Session with Drs. Ben Solomon and Ross Camidge on ALK Inhibition for Advanced NSCLC (audio)

GRACEcast Lung Cancer Audio

English - November 21, 2011 16:00 - 12 minutes - 11.7 MB - ★★★★★ - 1 rating
Science Health & Fitness Medicine grace cancergrace gracecast lung cancer nsclc chemotherapy chemo radiation non Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: ALK Inhibition: Who to Screen, and Additional Options for ALK-Positive Patients, by Dr. Ross Camidge (audio)

Next Episode: Detection and Work-Up of Lung Nodules, by David Yankelevitz (audio)

Drs. Ben Solomon (Peter MacCallum Cancer Center in Melbourne) and Ross Camidge (Univ. of Colorado) answer Qs on ALK rearrangements and crizotinib (XALKORI) for advanced non-small cell lung cancer (NSCLC).